NR4A1 and prostate carcinoma: However, BT-20 cells originate from a triple-negative breast tumour and do not account for the hormone-dependent regulation of KLKs mentioned earlier and their expression in hormone-dependent malignancies, such as hormone-receptor-positive breast cancer, accounting for the majority of breast tumours, as well as prostate cancer or ovarian cancer [12].